Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.47 USD | +1.73% | -5.27% | -38.61% |
Jul. 01 | InfuSystem Holdings, Inc.(NYSEAM:INFU) added to Russell 2000 Growth-Defensive Index | CI |
Jul. 01 | InfuSystem Holdings, Inc.(NYSEAM:INFU) added to Russell 2000 Defensive Index | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company sustains low margins.
- With an expected P/E ratio at 57.09 and 18.31 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-38.61% | 138M | C- | ||
-7.22% | 178B | C+ | ||
-6.72% | 98.53B | C | ||
-7.50% | 65.18B | A | ||
-10.57% | 44.13B | B- | ||
+8.92% | 44.05B | B- | ||
+14.41% | 42.51B | B+ | ||
+9.65% | 28.41B | B | ||
+22.00% | 25.31B | A- | ||
-9.13% | 23.31B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- INFU Stock
- Ratings InfuSystem Holdings, Inc.